ReposiTrak NYSE: TRAK reported fiscal 2026 revenue growth, wider operating margins and higher earnings as the company continued shifting its business mix toward recurring software-as-a-service revenue while reducing operating expenses. The FDA has since extended the compliance date to July 20, 2028, and Congress has directed the agency not to enforce the food traceability rule before that date, Merrill said. He added that ReposiTrak expects customer activity could increase as the industry prepares for the n ...